PanOptix® Trifocal IOL
An overview of important clinical data from experienced surgeons
sponsored by Alcon
With several prospective clinical studies now complete, and the number of surgeons with experience of the platform increasing, the evidence base for Alcon's PanOptix® Trifocal IOL has grown considerably. In this clinical update, you can find an overview of recently published and presented PanOptix® safety and efficacy data from experienced surgeons, as well as a comparison with other IOL options available on the market.
© 2020 Alcon Inc. 06/20 US-ACP-2000166
Enjoy our FREE content!
Log in or register to gain full unlimited access to all content on the The Ophthalmologist site. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine